Also mention the ‘n’ number in all the experiments involved for invitro and invivo.
Another puzzling experiment is the schedule for the in vivo work. Since the authors missed to add Figure 4A for timeline, based on Methods section the rats were treated for 5 days with TTFields and or sorafenib and a day later the rays were sacrificed. While a short “acute” follow-up is welcome the most important experiment should allow the follow-up for much more days to indeed observe the effect of TTFields added to sorafenib. I could not find an explanation for not including a long term follow-up. In my opinion, this is a key therapeutically experiment which must be done and included in the study.